Endovascular Exclusion of Thoracoabdominal and/or Paravisceral Abdominal Aortic Aneurysm
Recruiting
N/A
Interventional Study
Thoracoabdominal Aortic Aneurysm
Paravisceral Abdominal Aortic Aneurysm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 250 (estimated)
- Sponsor
- Warren J. Gasper, MD · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This is a study to assess the safety and effectiveness of endovascular treatment of thoracoabdominal (TAAA) and paravisceral abdominal (PVAAA) aortic aneurysms. The investigational operation involves placing a stent-graft over the aortic aneurysm.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
1. Aortic aneurysms:
* greater than or equal to 6 cm in diameter in men,
* greater than or equal to 5.5 cm in diameter in women,
* and/or larger than 5 cm in diameter and enlarging at a rate of more than 5 mm/year,
* and/or iliac aneurysms larger than 4 cm in diamete…
Contacts